MetLife Investment Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $117K | Sell |
8,198
-653
| -7% | -$9.33K | ﹤0.01% | 2458 |
|
2025
Q1 | $92.9K | Buy |
8,851
+203
| +2% | +$2.13K | ﹤0.01% | 2561 |
|
2024
Q4 | $105K | Buy |
8,648
+24
| +0.3% | +$291 | ﹤0.01% | 2598 |
|
2024
Q3 | $127K | Sell |
8,624
-194
| -2% | -$2.85K | ﹤0.01% | 2530 |
|
2024
Q2 | $127K | Sell |
8,818
-739
| -8% | -$10.7K | ﹤0.01% | 2479 |
|
2024
Q1 | $156K | Buy |
9,557
+22
| +0.2% | +$358 | ﹤0.01% | 2329 |
|
2023
Q4 | $142K | Sell |
9,535
-183
| -2% | -$2.73K | ﹤0.01% | 2421 |
|
2023
Q3 | $109K | Buy |
9,718
+14
| +0.1% | +$157 | ﹤0.01% | 2533 |
|
2023
Q2 | $97.6K | Buy |
9,704
+482
| +5% | +$4.85K | ﹤0.01% | 2694 |
|
2023
Q1 | $86.7K | Buy |
9,222
+19
| +0.2% | +$179 | ﹤0.01% | 2605 |
|
2022
Q4 | $112K | Buy |
9,203
+45
| +0.5% | +$550 | ﹤0.01% | 2545 |
|
2022
Q3 | $114K | Sell |
9,158
-222
| -2% | -$2.76K | ﹤0.01% | 2620 |
|
2022
Q2 | $184K | Buy |
9,380
+480
| +5% | +$9.42K | ﹤0.01% | 2383 |
|
2022
Q1 | $232K | Buy |
+8,900
| New | +$232K | ﹤0.01% | 2267 |
|
2019
Q2 | – | Sell |
-457
| Closed | -$14.7K | – | 2476 |
|
2019
Q1 | $14.7K | Buy |
457
+358
| +362% | +$11.5K | ﹤0.01% | 2357 |
|
2018
Q4 | $3.12K | Buy |
+99
| New | +$3.12K | ﹤0.01% | 2513 |
|